Skip To Main Content
Heng-ying Zhang on Muck Rack

Heng-ying Zhang

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Heng-ying

Contact Heng-ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

AAV-mediated GPR173 gene therapy attenuates long-term refractory epilepsy by enhancing synaptic GABA A receptor expression

|
By Li-Yang Zhang, Yi-Hao Li, Xin Yan, Ju-Fang He, Yan-yan Sun, Fei-xu Jiang, Heng-ying Zhang, Jun-ming Ren, Zhou-jian Xiao, Ding-xuan Zeng
| Nature Verified
Abstract Approximately 30% of epilepsy patients are drug-resistant, and sustained seizure activity often reduces responsiveness to conventional therapies. This study aimed to evaluate the therapeutic efficacy and safety of adeno-associated virus (AAV)-mediated GPR173 gene therapy in two refractory epilepsy mouse models, including delayed-treatment epilepsy (DTE) and drug-resistant epilepsy (DRE), and to investigate its underlying molecular mechanisms.
Open in Who Shared Issue with article?
See all 1 articles